Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Chenodeoxycholic acid
Cat. No.:
OB0225LY-0313
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Chenodeoxycholic acid is an important bile acid that is extensively involved in lipid metabolism processes.
Synonym:
CDCA; Chenodiol; 474-25-9; Chenix; Chenic acid; Chenodeoxycholate; Gallodesoxycholic acid; Chendol; Anthropodeoxycholic acid; 5beta-Cholanic acid-3alpha, 7alpha-diol
CAS No.:
474-25-9
Compound CID:
10133
Formula:
C24H40O4
Formula Weight:
392.57
Specification
Relative Density:
1.129 g/cm3.
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Chenodeoxycholic acid plays an important role in the study of liver physiology and the study of cholesterol metabolism.
Library Information
Targets:
Nuclear receptors; Ion channels
Receptors:
FXR; Potassium channel
Pathways:
Membrane transporter/Ion channel; Autophagy; Metabolism
Plate Number:
AOCL-5
Plate Location:
a6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
40 mg/mL; 101.89 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
79 mg/mL; 201.23 mM
